What primary care physicians think about insulin initiation in type 2 diabetes: a feld-based study

What primary care physicians think about insulin initiation in type 2 diabetes: a feld-based study

Background/aim: A signifcant number of patients with type 2 diabetes mellitus require insulin and little is known about the possiblephysician-related factors that could cause a delay in the initiation of insulin treatment in patients with type 2 diabetes. Tis study aimedto evaluate those factors.Materials and methods: A total of 87 family physicians working at 36 family health centers in urban Malatya participated in our studyon a voluntary basis. A self-administered survey form was structured to gather the views of the primary care physicians. Te survey wasdeveloped based on a review of the literature. Te survey consisted of Likert scale item questions regarding knowledge about the diseaseof diabetes mellitus and the views of the primary care physicians regarding insulin initiation for type 2 diabetic patients.Results: Almost half of the participants (42.5%, n = 37) felt incompetent in the starting dosage adjustment and 40.2% (n = 35) of theparticipants felt incompetent in maintaining the appropriate dosage adjustment. In terms of sex, female family physicians were found tobe more uncertain about the timing of initiating insulin treatment for diabetic patients.Conclusion: Tis study shows the necessity of continuous education activities and interventions to promote motivation in familyphysicians to improve care of diabetic patients in primary care.

___

  • 1. Furdell, EL. Fatal Tirst: Diabetes in Britain until Insulin. Boston, MA, USA: Brill Academic Publishers; 2009.
  • 2. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963–1972.
  • 3. Peyrot M, Rubin R, Lauritzen T, Skovlond S, Snoek F, Mathews D. Resistance to insulin therapy among patients and providers. Diabetes Care 2005; 28: 2673–2679.
  • 4. Brown J, Nichols G, Perry A. Te burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27: 1535–1540.
  • 5. [No authors listed.] UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991; 34: 877–890.
  • 6. Kasje WN DP, Stewart RE, de Graef PA, Haaijer-Ruskamp FM. An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice. J Eval Clin Pract 2006; 12: 613–621.
  • 7. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002; 26: 18–24.
  • 8. Ross A, Tildesley H, Ashkenas J. Barriers to efective insulin treatment: the persistence of poor glycemic control in type 2 diabetes. Cur Med Res Opin 2011; 27: 13–20.
  • 9. Brod M, Kongso J, Lessard S, Christensen T. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18: 23–32.
  • 10. Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, Volk RJ. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med 2006; 4: 23–31.
  • 11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.
  • 12. Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis 2013; 10: 120180.
  • 13. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract 2008; 62: 860–868.
  • 14. Nam S, Chesla C, Stotts N, Kroon L, Janson L. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes care 2010; 33: 1747–1749.
  • 15. Cabana D, Rand C, Powe R, Wu W, Wilson H, Abboud C. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458–1468.
  • 16. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, Nathan DM. Measuring psychological insulin resistance barriers to insulin use. Diabetes Educ 2008; 34: 511– 517.
  • 17. Makuc J, Predikaka K. Insulin allergy. Zdrav Vestn 2008; 77: 757–759 (in Slovenian with an abstract in English).
  • 18. Peyrot M, Barnett A, Meneghini L, Schumm-Draeger P. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diabet Med 2012; 29: 682–689.
  • 19. Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, Giusti J, McCartney R, Lee Y, Bonsignore P et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med 2011; 171: 362 –364.
  • 20. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes – causes, efects and coping strategies. Diabetes Obes Metab 2007; 9: 799–812.
  • 21. Ab E, Denig P, van Vliet T, Dekker JH. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Family Practice 2009; 10: 24.
  • 22. Cabana M, Ebel B, Cooper-Patrick L, Powe N, Rubin H, Rand C. Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med 2000; 154: 685–693.
  • 23. Aktürk Z, Acemoğlu H. Comprehensive care and its evaluation in family medicine. Eurasian Journal of Family Medicine 2012; 1: 23–28 (in Turkish with an abstract in English).
  • 24. Rackel R. Improving patient acceptance and adherence in diabetes management: A focus on insulin therapy. Adv Ter 2009; 26: 838–846.
  • 25. Jackson L, Yuan L. Family physicians managing tuberculosis. Qualitative study of overcoming barriers. Can Fam Physician 1997; 43: 649–655.
  • 26. Set T, Aktürk Z, Büyüklü M, Cansever Z, Avşar ÜG, Avşar Ü, Işık M, Acemoğlu H. Improving electrocardiogram interpreting skills among primary care physicians in Turkey. Turk J Med Sci 2012; 42: 1028–32.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Human papillomavirus: a potential risk factor for colorectal carcinoma?

Alpaslan TANOĞLU, Ahmet Ziya BALTA, Ufuk BERBER

The first PTPN11 mutations in hotspot exons reported in Moroccan children with Noonan syndrome and comparison of mutation rate to the previous studies

IHSSANE EL BOUCHIKHI, IMANE SAMRI, MOHAMMED IRAQUI HOUSSAINI, SAAID TRHANINT, LAILA BOUGUENOUCH, HANANE SAYEL, MOUSTAPHA HIDA, SAMIR ATMANI, KARIM OULDIM

Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates lipopolysaccharide-induced cellular injury in lung alveolar epithelial cells

SİNAN VICIL, SUAT ERDOGAN

The relationship between hepatitis serology of ambulance attendants and duration of education

Ertuğrul GÜÇLÜ, Aziz ÖĞÜTLÜ, Oğuz KARABAY

Effect of keratinocyte growth factor on growth and transdifferentiation of primary alveolar epithelial type II cells

Xiuxiang LIU, ZHICHUN FENG, Chunmei TIAN, Xiangyong KONG, YUMEI WU, Changjun LV

Efect of keratinocyte growth factor on growth and transdiferentiation of primary alveolar epithelial type II cells

Yumei WU, Xiuxiang LIU, Zhichun FENG, Chunmei TIAN, Xiangyong KONG, Changjun LV

Selenium status in blood, urine, and hair samples of newly diagnosed pediatric cancer patients

SERAP KARAMAN, BANU MANSUROĞLU, KADRİYE KIZILBEY, SERAP DERMAN, AFİFE BİNNAZ HAZAR

Pandemic H1N1 IgG levels in healthcare workers

Viroj WIWANITKIT

Treatment of ankylosing spondylitis

İsmail SARI, Mehmet Akif ÖZTÜRK, Nurullah AKKOÇ

The effects of atorvastatin on antioxidant/antiinfammatory properties of HDLs in hypercholesterolemics

İbrahim Özkan ALATAŞ, Ahmet MUSMUL, Gülşen ÇİFTÇİ AKALIN, Aysen AKALIN, İpek ERTORUN